Skip to main content
Caplight Logo









Inanovate, Inc.

Inanovate, Inc.

Private
Sioux Falls, South DakotaHealthcare & Life Scienceshttps://inanovate.com/

Last Round

VC Round

Jul 2, 2025

Total Funding Raised

$6.4M

Company Overview

Inanovate, Inc. is a biotechnology company that develops diagnostic tests for cancer and other diseases using its proprietary Bio-ID multiplexed protein quantification platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

medical diagnosticsdiagnostic testingmultiplexed protein quantificationbiomarker analysisclinical laboratoryCLIA-certified laboratoryCLIAmedical devicesmicrofluidicspoint-of-care testingPOCTrazor-and-blade modelassay developmentprecision medicinebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inanovate, Inc. Comparables

Compare Inanovate, Inc. with similar companies based on industry and business-model similarity.

Inanovate, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quansys Biosciences
77%
Thermo Fisher Scientific Inc.
74%
ProteoWise
73%

Inanovate, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 2, 2025
VC RoundNov 15, 2024
VC RoundJun 12, 2024
DebtApr 27, 2020
GrantAug 21, 2019
Series C
Apr 3, 2019

Key People

Founding team and executive leadership

Greg McGuinness

Chief Executive Officer and Board Member

Executive Team

Inanovate, Inc. Investors

Notable investors and investment history

Inanovate, Inc. investors
InvestorRounds
National Cancer InstituteGrant
South Dakota Equity PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    $808K raised in a VC Round.

  • Nov 15, 2024

    $3.5M raised in a VC Round.

Inanovate, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inanovate, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inanovate, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSioux Falls, South Dakota
Employee Range15
Year Founded2006
Last FundingJul 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?